Evidence map›Paper›PMID 42420585›Full record

ArticleEMBO molecular medicine2026

Dermal papillary fibroblasts promote persistent granulation tissue formation in junctional epidermolysis bullosa.

Mohammad R A Khan, Priya Garcha, Viktorija Lapinska, Yuanjinze Nie, Ilaria Di Girolamo, Christina Philippeos, Edel A O'Toole, John F Marshall, Gernot Walko, John A McGrath and 4 more

Abstract read
In one paragraph

Article in EMBO molecular medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Mohammad R A KhanCell Biology & Cutaneous Research, Blizard Institute, Queen Mary University of London, London, UK.
Priya Garcha *Cell Biology & Cutaneous Research, Blizard Institute, Queen Mary University of London, London, UK.
Viktorija Lapinska *Cell Biology & Cutaneous Research, Blizard Institute, Queen Mary University of London, London, UK.
Yuanjinze NieTranslational and Clinical Research Institute (Dermatology), Newcastle University, Newcastle upon Tyne, UK.ORCID http://orcid.org/0009-0006-4483-7357
Ilaria Di GirolamoCentre for Oral Immunobiology and Regenerative Medicine, Institute of Dentistry, Queen Mary University of London, London, UK.ORCID http://orcid.org/0009-0003-4808-0337
Christina PhilippeosCentre for Gene Therapy & Regenerative Medicine, King's College London, London, UK.ORCID http://orcid.org/0000-0001-8654-0291
Edel A O'TooleCell Biology & Cutaneous Research, Blizard Institute, Queen Mary University of London, London, UK.
John F MarshallBarts Cancer Institute, Cancer Research UK Centre of Excellence, Queen Mary University of London, Charterhouse Square, London, UK.ORCID http://orcid.org/0000-0002-0494-2295
Gernot WalkoCentre for Oral Immunobiology and Regenerative Medicine, Institute of Dentistry, Queen Mary University of London, London, UK.ORCID http://orcid.org/0000-0002-8504-1738
John A McGrathSt John's Institute of Dermatology, King's College London, London, UK.
Nick ReynoldsTranslational and Clinical Research Institute (Dermatology), Newcastle University, Newcastle upon Tyne, UK.
Fiona M WattCentre for Gene Therapy & Regenerative Medicine, King's College London, London, UK.ORCID http://orcid.org/0000-0001-9151-5154
Matthew CaleyCell Biology & Cutaneous Research, Blizard Institute, Queen Mary University of London, London, UK. m.caley@qmul.ac.uk.ORCID http://orcid.org/0000-0003-0504-9922
Emanuel RognoniCell Biology & Cutaneous Research, Blizard Institute, Queen Mary University of London, London, UK. e.rognoni@qmul.ac.uk.ORCID http://orcid.org/0000-0001-6050-2860

Funding

DEBRA UK (DEBRA) GR000049DEBRA UK (DEBRA) GR000077Great Ormond Street Hospital for Children (GOSH) V4622QM | Barts and The London School of Medicine and Dentistry G-002411
6 · The paper itself

Abstract

The skin is composed of multiple fibroblast subpopulations with different functions in homeostasis and repair, but their role in skin diseases is largely unknown. Junctional epidermolysis bullosa (JEB) is a hereditary skin disorder characterised by severe skin fragility and aberrant granulation tissue formation, caused by loss-of-function variants in basement membrane proteins, including laminin-332. We developed JEB-like organotypic (OT) cultures with distinct fibroblast subpopulations and explored their role in an inducible JEB in vivo disease model, mimicking key features of the human disease. Mechanistically, papillary fibroblasts are highly increased in the granulation tissue of blistered JEB skin, promoting pathological αvβ6 integrin and TGFβ signalling in JEB keratinocytes. Treatment with the TGFβ receptor inhibitor RepSox not only normalised aberrant cell proliferation, differentiation, and cytokine signalling in JEB OTs but also reduced aberrant granulation tissue formation and skin blistering in laminin-332-depleted mice. Collectively, our study reveals that papillary fibroblasts promote JEB pathogenesis through increasing αvβ6 integrin and TGFβ signalling and disruption of these pathological signalling interactions significantly improved skin health and regeneration in JEB.

Indexed as

Epidermolysis Bullosa, JunctionalFibroblastsGranulation TissueAnimalsAntigens, NeoplasmCell Adhesion MoleculesCells, CulturedDisease Models, AnimalHumansIntegrinsKalininKeratinocytesMiceSignal TransductionSkinTransforming Growth Factor betaAntigens, NeoplasmCell Adhesion Moleculesintegrin alphavbeta6IntegrinsKalininTransforming Growth Factor beta

Identifiers

PMID42420585
PMCPMC13470471

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.